Iguratimod
A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.
Product Specifications
CAS Number
123663-49-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
374.3679
Molecular Formula
C17H14N2O6S
Notes
Research use only, not for human use.
Receptor
COX-2|MIF
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037007-ML405 100 µL
IL2RG, ID (IL2RG, Cytokine receptor common subunit gamma, Interleukin-2 receptor subunit gamma, gammaC, p64, CD132) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
MBS6234407-01 0.1 mL
PDCD7 (ES18, FLJ54213, HES18, MGC22015, Programmed Cell Death Protein 7) (MaxLight 750)
Sign In for Pricing
View Details MBS6234407-02 5x 0.1 mL
PDCD7 (ES18, FLJ54213, HES18, MGC22015, Programmed Cell Death Protein 7) (MaxLight 750)
Sign In for Pricing
View Details 
A1334-33P-APC 200 µL
ALDH1A1 (Retinal Dehydrogenase 1, RalDH1, RALDH 1, Aldehyde Dehydrogenase Family 1 Member A1, Aldehyde Dehydrogenase, Cytosolic, ALHDII, ALDH-E1, ALDH1A1, ALDC, ALDH1, PUMB1) (APC)
Sign In for Pricing
View Details